Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

New treatments of neurodegenerative diseases involving the cellular recycling machinery

EF 2017-18

Résumé
Neurodegenerative diseases are among the most serious health problems facing modern society. Many of these disorders become more common with advancing age, including Alzheimer's disease, Parkinson's disease, Huntington's disease and many others. The burden of these neurodegenerative diseases is growing inexorably as the population ages, with enormous economic and human costs. The need for new medicines is resounding, since current treatments are only able to help the cognitive and behavioral symptoms, to slow down the disease progression, but are not able to prevent nor cure. These diseases are characterized by the accumulation of toxic proteins naturally produced by our bodies. At the same time, as we age, our recycling machinery in each of our cells starts to be less active and less efficient. We think that increasing the recycling activity in our cells transiently with drugs could clear these proteins and restore all cognitive capacities. A mouse model of Alzheimer's disease has already shown that activating this process brought complete cure. However, our knowledge about how it happened and other potential targets is very limited. We are proposing to further investigate the molecular pathways involved in cellular recycling and explore potential therapeutic drugs in worm and mouse models of Alzheimer's and Parkinson's disease. Our preliminary data shows that some already approved drugs might be used for new purpose and have a positive impact for neurodegenerative diseases. Our work will provide new insights about the disease progression and might uncover new directions for new treatments. This project has the potential of significantly improve the outcomes of many neurodegenerative diseases.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
387257
Name
Paquette Mathieu
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
New treatments of neurodegenerative diseases involving the cellular recycling machinery
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Autophagy/Lysosome; Immunofluorescence; Immunohistochimie; Maladie D'Alzheimer; Maladie De Parkinson; Maladies Neurodégénératives; Modèles De Souris; Modèles De Vers (C.Elegans); Phosphorylation; Signalisation Moléculaire
Abstract
Neurodegenerative diseases are among the most serious health problems facing modern society. Many of these disorders become more common with advancing age, including Alzheimer's disease, Parkinson's disease, Huntington's disease and many others. The burden of these neurodegenerative diseases is growing inexorably as the population ages, with enormous economic and human costs. The need for new medicines is resounding, since current treatments are only able to help the cognitive and behavioral symptoms, to slow down the disease progression, but are not able to prevent nor cure. These diseases are characterized by the accumulation of toxic proteins naturally produced by our bodies. At the same time, as we age, our recycling machinery in each of our cells starts to be less active and less efficient. We think that increasing the recycling activity in our cells transiently with drugs could clear these proteins and restore all cognitive capacities. A mouse model of Alzheimer's disease has already shown that activating this process brought complete cure. However, our knowledge about how it happened and other potential targets is very limited. We are proposing to further investigate the molecular pathways involved in cellular recycling and explore potential therapeutic drugs in worm and mouse models of Alzheimer's and Parkinson's disease. Our preliminary data shows that some already approved drugs might be used for new purpose and have a positive impact for neurodegenerative diseases. Our work will provide new insights about the disease progression and might uncover new directions for new treatments. This project has the potential of significantly improve the outcomes of many neurodegenerative diseases.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Paquette, Mathieu
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~